key: cord-0873959-72r6vmm6 authors: Hoyer, Carolin; Weber, Lenja; Sandikci, Vesile; Ebert, Anne; Platten, Michael; Szabo, Kristina title: Decreased admissions and change in arrival mode in patients with cerebrovascular events during the first surge of the COVID-19 pandemic date: 2020-11-16 journal: Neurol Res Pract DOI: 10.1186/s42466-020-00094-w sha: a7ec7908b7b847f924afc89003183172c5bf8feb doc_id: 873959 cord_uid: 72r6vmm6 BACKGROUND AND PURPOSE: Investigating clinical characteristics of patients presenting with cerebrovascular events during the pandemic may provide valuable insight into further understanding the phenomenon of decreased stroke admissions during the COVID-19 pandemic. METHOD: Data of patients presenting with a cerebrovascular event to the emergency department during weeks 12–17/2020 were compared to data from the respective weeks in 2019. RESULTS: A significant reduction in the number of admissions by 35.9% (p = 0.005) was observed during the COVID-19 epoch. In addition, significantly more patients arrived by ambulance during the COVID-19 epoch (2019: 75.7%, 2020: 94.2%; p = 0.001). CONCLUSION: Our data may have implications as to how campaigns raising awareness for serious medical conditions in the context of the pandemic should be framed. Declining rates of admissions for cerebrovascular events (CVEs) and an impact on reperfusion therapy rates were observed during the first surge of the coronavirus disease 2019 (COVID-19) pandemic earlier this year. This applied regardless of the extent of COVID-19related re-allocation of resources in different countries [1] [2] [3] [4] [5] . Avoidance behavior caused by fear of in-hospital infection was suggested as underlying this phenomenon [6] , which in the case of undiagnosed or untreated strokes may have harmful consequences. Given the current increase in the number of COVID-19 cases and an incipient second wave, it is paramount to take appropriate measures to prevent this particular aspect of recent history from repeating. Obtaining detailed demographic and clinical information of patients presenting with CVEs during the pandemic may provide valuable information to this end. We analyzed data of patients admitted for CVEs (transient ischemic attack (TIA), ischemic stroke, intracerebral hemorrhage) to the Department of Neurology, University Medical Centre Mannheim, Germany, in weeks 1-17/2020. Week 12/2020, when extended measures for social distancing were implemented, was designated as the beginning of the COVID-19 epoch. Poisson regression was used to test if the rate of admissions and reperfusion therapies for ischemic stroke changed as a function of year, epoch and year-by-epoch interaction (reflecting the impact of the pandemic). We found a significant reduction of the number of admissions due to a CVE during the COVID-19 epoch by 35.9% (rate ratio 0.64, 95% confidence interval (CI) 0.43-0.96, p = 0.005); Mechanical thrombectomy (with/without IVT), was performed in 9 and 8 patients, respectively. Group comparisons between weeks 12-17/2019 vs. 2020 were performed (Table 1) : No differences were found regarding age, gender and vascular risk factors, NIHSS scores, rate of minor strokes, proportion of patients with TIA and symptom-to-door times. We also identified a change in admission mode between 2019 and 2020 with significantly more admissions via ambulance in 2020 ( Fig. 1 , p = 0.001). Previous investigations found a decline of presentations in particular due to TIA or minor stroke during the pandemic [1, 4] . Moreover, changes in recanalization therapy rates were attributed to underlying presentation delays [5] , which may in part be caused by patients' indecisiveness as to whether they should present to a hospital. In a study of emergency department (ED) patients with neurological complaints, we previously identified a shift towards older and more severely affected patients with consecutive higher numbers of admissions to escalated care during the pandemic [7] . While we did not observe such disproportionate changes in demographics or stroke characteristics, we found a significant difference in admission modes: while overall fewer patients presented to the hospital during the COVID epoch in 2020, the vast majority of those who did arrived by ambulance. A UK investigation reported no significant reduction in ambulance call-outs for stroke during the lockdown, the authors concluded that patients do not hesitate to call an ambulance when experiencing stroke symptoms [8] . However, previous studies showed that a relevant portion of stroke patients arrive via other modes of transportation such as private or public transport [9] , and that these patients are usually younger and less severely affected than patients arriving by ambulance [10] . Hence it may be precisely this subgroup of selfpresenting or privately transported patients we have seen fewer of during the pandemic. We can only speculate about the reasons behind this observation but the perceived threat of contracting an infection while waiting in often crowded EDs may be a contributing factor. It bears mentioning that ours is a single-center study examining not the entire duration of the lockdown and beyond, thus limiting the generalization of our results. Longerterm analyses are needed to further elucidate on healthrelated behaviors pertaining to if, when and how emergency presentations are initiated in the context of the pandemic. In light of our findings, it appears nonetheless adequate to advise patients to call an ambulance when noticing acute-onset neurological deficits of any kind and to frame respective campaigns accordingly. Finally, it remains essential for healthcare providers to clearly communicate that stroke care remains a priority and that swift assessment in a safe environment is guaranteed regardless of mode of presentation. Decrease in hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID-19 era Acute stroke in times of the COVID-19 pandemic: A multicenter study Collateral effect of Covid-19 on stroke evaluation in the United States Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population Impact of the COVID-19 outbreak on acute stroke pathways -insights from the Alsace region in France Where are all the patients? Addressing COVUD-19 fear to encourage patients to seek emergency care NEJM Catalyst Changes in demographic and diagnostic spectra of patients with neurological symptoms presenting to an emergency department during the COVID-19 pandemic: A retrospective cohort study Emergency ambulance services for heart attack and stroke during UK's COVID-19 lockdown A retrospective study investigating: Factors associated with mode of arrival and emergency department management for patients with acute stroke An observational study of patient characteristics associated with the mode of admission to acute stroke services in north east Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations Not applicable. Carolin Hoyer Designed and conceptualized study; major role in the acquisition of data; wrote the manuscript. Lenja Weber Major role in the acquisition of data; revised the manuscript for intellectual content. Vesile Sandikci Major role in data analysis; revised the manuscript for intellectual content. Anne Ebert Major role in data analysis; revised the manuscript for intellectual content. Michael Platten Designed and conceptualized study; revised the manuscript for intellectual content. Kristina Szabo Designed and conceptualized study; major role in the acquisition of data, revised the manuscript for intellectual content. All authors have given their approval to the final draft of the manuscript.Funding CH receives funding within the Olympia Morata Program of Heidelberg University. CH and KS receive funding within the Sonderförderlinie COVID-19 Forschung of the federal state Baden-Württemberg. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. The study was approved by the local ethics committee, IRB number 2018-502 N-MA. Written informed consent was waived due to the retrospective character of the investigation. Not applicable. The authors declare that they have no competing interests.Received: 21 October 2020 Accepted: 2 November 2020